However, another study showed FXR signaling was activated in obese human intestines, and intestine-selective FXR inhibitor improved obesity and metabolic syndrome in HFD-induced obese mice [80]. Here, NR1H4 is linked to obesity due to melanocortin 4 receptor deficiency.